These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20573077)

  • 1. Icatibant.
    Dubois EA; Cohen AF
    Br J Clin Pharmacol; 2010 May; 69(5):425-6. PubMed ID: 20573077
    [No Abstract]   [Full Text] [Related]  

  • 2. Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.
    Firinu D; Barca MP; Serusi L; Lorrai MM; Peralta MM; Manconi PE; Del Giacco SR
    Int J Immunopathol Pharmacol; 2012; 25(1):269-73. PubMed ID: 22507340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary angioedema--therapies old and new.
    Morgan BP
    N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic agents for hereditary angioedema.
    Giavina-Bianchi P; Motta A; Kalil J
    N Engl J Med; 2011 Jan; 364(1):85; author reply 86. PubMed ID: 21208116
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.
    Farkas H; Reshef A; Aberer W; Caballero T; McCarthy L; Hao J; Nothaft W; Schranz J; Bernstein JA; Li HH
    J Allergy Clin Immunol Pract; 2017; 5(6):1671-1678.e2. PubMed ID: 28601641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
    Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
    Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icatibant as acute treatment for hereditary angioedema in adults.
    Farkas H
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life experience with long-term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: Effectiveness and cost.
    Rasmussen ER; Aagaard L; Bygum A
    Ann Allergy Asthma Immunol; 2016 May; 116(5):476-7. PubMed ID: 27017563
    [No Abstract]   [Full Text] [Related]  

  • 9. Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.
    Piras V; Alves F; Gonçalo M
    Dermatol Ther; 2019 Nov; 32(6):e13098. PubMed ID: 31579975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report of icatibant treatment in a pregnant patient with hereditary angioedema.
    Farkas H; Kőhalmi KV; Veszeli N; Tóth F; Varga L
    J Obstet Gynaecol Res; 2016 Aug; 42(8):1026-8. PubMed ID: 27093898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of icatibant (HOE-140, JE-049).
    Cruden NL; Newby DE
    Expert Opin Pharmacother; 2008 Sep; 9(13):2383-90. PubMed ID: 18710362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries.
    Caballero T; Aberer W; Longhurst HJ; Maurer M; Zanichelli A; Perrin A; Bouillet L; Andresen I;
    J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1214-1222. PubMed ID: 28370444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema].
    Leimgruber A
    Rev Med Suisse; 2011 Jan; 7(278):103-5. PubMed ID: 21400938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
    Cicardi M; Banerji A; Bracho F; Malbrán A; Rosenkranz B; Riedl M; Bork K; Lumry W; Aberer W; Bier H; Bas M; Greve J; Hoffmann TK; Farkas H; Reshef A; Ritchie B; Yang W; Grabbe J; Kivity S; Kreuz W; Levy RJ; Luger T; Obtulowicz K; Schmid-Grendelmeier P; Bull C; Sitkauskiene B; Smith WB; Toubi E; Werner S; Anné S; Björkander J; Bouillet L; Cillari E; Hurewitz D; Jacobson KW; Katelaris CH; Maurer M; Merk H; Bernstein JA; Feighery C; Floccard B; Gleich G; Hébert J; Kaatz M; Keith P; Kirkpatrick CH; Langton D; Martin L; Pichler C; Resnick D; Wombolt D; Fernández Romero DS; Zanichelli A; Arcoleo F; Knolle J; Kravec I; Dong L; Zimmermann J; Rosen K; Fan WT
    N Engl J Med; 2010 Aug; 363(6):532-41. PubMed ID: 20818888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey.
    Maurer M; Bork K; Martinez-Saguer I; Aygören-Pürsün E; Botha J; Andresen I; Magerl M
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):163-169. PubMed ID: 30176179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging therapies to prevent hereditary angioedema attacks.
    Lumry WR
    Am J Manag Care; 2018 Aug; 24(14 Suppl):S299-S307. PubMed ID: 30132644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icatibant for hereditary angioedema.
    Gras J
    Drugs Today (Barc); 2009 Dec; 45(12):855-64. PubMed ID: 20135020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedema.
    Hakl R; Kuklínek P; Sobotková M; Krčmová I; Králíčková P; Vachová M; Hanzlíková J; Nováčková M; Svoboda M; Kováčová I; Litzman J
    Clin Exp Allergy; 2022 Aug; 52(8):994-997. PubMed ID: 35662289
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study.
    Hide M; Fukunaga A; Maehara J; Eto K; Hao J; Vardi M; Nomoto Y
    Allergol Int; 2020 Apr; 69(2):268-273. PubMed ID: 31672405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Several new treatment possibilities of hereditary angio-oedema].
    Aabom AL; Palarasah Y; Bygum A
    Ugeskr Laeger; 2012 Aug; 174(34):1894-8. PubMed ID: 22909569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.